Biotech a possible reuse of Potrero power plant site

(San Francisco Business Times subscription required for full article.)

San Francisco’s top developers are lining up for the chance to turn what was once one of California’s dirtiest energy generators into one of the city’s most promising development sites. Genon Energy Services LLC, formerlyMirant Corp., has issued a request for qualifications to at least 50 national and local developers that might be interested in acquiring the now-defunct Potrero power plant — a 22-acre central waterfront site that brings with it huge potential as well as environmental headaches. The site could be redeveloped for offices, institutional use or biotech space.

Giant biotech site put on the block

Six months after entitling an 82-acre waterfront commercial campus on Oyster Point in South San Francisco, owners Shorenstein Properties and SKS Development are quietly putting the huge property on the market.
The partnership has retained both Eastdil Secured and Cassidy Turley, pursuing a dual strategy of seeking a buyer while also reaching out to potential tenants. The property, which is likely to hit the market next week, is entitled for 2.25 million square feet and 20 acres of parkland.

Tech boom spurs more bio building

The Salesforce effect is sweeping down the Peninsula.
HCP Inc. plans to build as much as 800,000 square feet of lab and office space on a 20-acre former U.S. Steel site in South San Francisco after buying the land from Genentech Inc. last month for $65 million.

Alexandria buys Shorenstein/SKS life sciences complex in Mission Bay for $290M

Six months after selling most of its land in Mission Bay to Salesforce.com Inc., Alexandria Real Estate Equities wants to jump back into the neighborhood with the $290 million purchase of 409-499 Illinois St.
Alexandria is in contract to buy the 450,000-square-foot, two-building life science complex that Shorenstein Properties and SKS Investments completed in 2008.
The complex is anchored by FibroGen Inc., which leases 239,000 square feet. The transaction has gone non-refundable, but has not closed yet.
Both Shorenstein and Alexandria declined to comment.

Shorenstein plans to sell FibroGen's Mission Bay home